[New antimicrobial agent series XVIII: Ceftriaxone].
D000042:Absorption; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control; D002443:Ceftriaxone / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects
D002443:Ceftriaxone